Table 1.
Patient clinical and demographic data.
| Severe COVID-19 |
Critical COVID-19 |
p Value | |
|---|---|---|---|
| Age (years) | 60.26 ± 15.96 | 66.65 ± 11.45 | 0.149 |
| Male | 12 (44.44%) | 15 (75.00%) | 0.111 |
| Comorbidities | 19 (70.37%) | 15 (75.00%) | 0.940 |
| Symptoms | |||
| paO2/FIO2 | 318.80 ± 63.62 | 137.90 ± 79.23 | <0.0001 |
| Days of illness before admission | 5.65± 1.62 | 5.77 ± 2.98 | 0.852 |
| Laboratory baseline | |||
| White blood cells (cells/µL) | 6664.00 ± 3841 | 13897 ± 1231 | <0.0001 |
| Neutrophils (cells/µL) | 68.34 ± 16.62 | 79.80 ± 13.01 | 0.012 |
| Lymphocytes (cells/µL) | 27.58 ± 19.17 | 12.02 ± 13.30 | 0.001 |
| Platelets (cells/µL) | 207333 ± 88056 | 271737 ± 139869 | 0.100 |
| C-reactive protein (mg/L) | 7.05 ± 7.57 | 13.67 ± 11.52 | 0.025 |
| Troponin (ng/mL) | 37.58 ± 109.70 | 311.80 ± 845.90 | 0.114 |
| Urea (mg/dL) | 34.89 ± 24.78 | 84.16 ± 94.24 | <0.001 |
| Creatinine (mg/dL) | 0.82 ± 0.19 | 1.10 ± 0.88 | 0.368 |
| Aspartate aminotransferase (U/L) | 43.33 ± 37.50 | 150.70 ± 419.20 | 0.237 |
| Alanine transaminase (U/L) | 34.76 ± 22.94 | 62.17 ± 74.60 | 0.002 |
| Gamma-Glutamyltransferase (U/L) | 46.37 ± 39.22 | 83.26 ± 96.73 | 0.062 |
| Lactate Dehydrogenase (U/L) | 306.8 ± 128.9 | 535.6 ± 552.1 | 0.021 |
| Albumin (g/dL) | 3.846 ± 0.409 | 3.210 ± 0.506 | <0.0001 |
| Days of hospital stay | 8.00 ± 4.019 | 18.80 ± 14.10 | <0.0001 |
| Survival | 25 (92.59%) | 12 (60.00%) | 0.026 |
Data are presented as mean ± SD or absolute number (percentage of group).